Kristiansen G, Fritzsche F, Wassermann K, Jager C, Tölls A, Lein M, et al. GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics. Br J Cancer. 2008;99:939-48 pubmed publisher

Braun M, Menon R, Nikolov P, Kirsten R, Petersen K, Schilling D, et al. The HOPE fixation technique--a promising alternative to common prostate cancer biobanking approaches. BMC Cancer. 2011;11:511 pubmed publisher

Scheble V, Braun M, Wilbertz T, Stiedl A, Petersen K, Schilling D, et al. ERG rearrangement in small cell prostatic and lung cancer. Histopathology. 2010;56:937-43 pubmed publisher

Fritzsche F, Kristiansen G, Riener M, Dietel M, Oelrich B. GOLPH2 expression may serve as diagnostic marker in seminomas. BMC Urol. 2010;10:4 pubmed publisher

Riener M, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi B, et al. Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology. 2009;49:1602-9 pubmed publisher

Fritzsche F, Riener M, Dietel M, Moch H, Jung K, Kristiansen G. GOLPH2 expression in renal cell cancer. BMC Urol. 2008;8:15 pubmed publisher

Wei S, Dunn T, Isaacs W, De Marzo A, Luo J. GOLPH2 and MYO6: putative prostate cancer markers localized to the Golgi apparatus. Prostate. 2008;68:1387-95 pubmed publisher